These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8619591)

  • 1. In vitro antibacterial activity and beta-lactamase stability of a new carbapenem, BO-2727.
    Inoue K; Hamana Y; Mitsuhashi S
    Antimicrob Agents Chemother; 1995 Oct; 39(10):2331-6. PubMed ID: 8619591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo antibacterial activities of BO-2727, a new carbapenem.
    Asahi Y; Miyazaki S; Yamaguchi K
    Antimicrob Agents Chemother; 1995 May; 39(5):1030-7. PubMed ID: 7625784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibacterial properties of BO-2727, a new carbapenem antibiotic.
    Kato Y; Otsuki M; Nishino T
    J Antimicrob Chemother; 1997 Aug; 40(2):195-203. PubMed ID: 9301984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of a new carbapenem antibiotic, BO-2727, with potent antipseudomonal activity.
    Nakagawa S; Hashizume T; Matsuda K; Sanada M; Okamoto O; Fukatsu H; Tanaka N
    Antimicrob Agents Chemother; 1993 Dec; 37(12):2756-9. PubMed ID: 8109950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo antibacterial activities of ER-35786, a new antipseudomonal carbapenem.
    Ohba F; Nakamura-Kamijo M; Watanabe N; Katsu K
    Antimicrob Agents Chemother; 1997 Feb; 41(2):298-307. PubMed ID: 9021183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of enhanced antipseudomonal activity of BO-2727, a new injectable 1-beta-methyl carbapenem.
    Hazumi N; Fuse A; Matsuda K; Hashizume T; Sanada M
    Antimicrob Agents Chemother; 1995 Mar; 39(3):702-6. PubMed ID: 7793876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro antibacterial activity and beta-lactamase stability of the new carbapenem LJC10,627.
    Yoshida M; Mitsuhashi S
    Eur J Clin Microbiol Infect Dis; 1990 Aug; 9(8):625-9. PubMed ID: 2209630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical characterization of novel tetrahydrofuranyl 1beta-methylcarbapenems: stability to hydrolysis by renal dehydropeptidases and bacterial beta-lactamases, binding to penicillin binding proteins, and permeability properties.
    Yang Y; Testa RT; Bhachech N; Rasmussen BA; Bush K
    Antimicrob Agents Chemother; 1999 Dec; 43(12):2904-9. PubMed ID: 10582880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.
    Zhanel GG; Golden AR; Zelenitsky S; Wiebe K; Lawrence CK; Adam HJ; Idowu T; Domalaon R; Schweizer F; Zhanel MA; Lagacé-Wiens PRS; Walkty AJ; Noreddin A; Lynch Iii JP; Karlowsky JA
    Drugs; 2019 Feb; 79(3):271-289. PubMed ID: 30712199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative in-vitro activity of meropenem against clinical isolates including Enterobacteriaceae with expanded-spectrum beta-lactamases.
    Chanal C; Sirot D; Chanal M; Cluzel M; Sirot J; Cluzel R
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():133-41. PubMed ID: 2808205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical comparison of imipenem, meropenem and biapenem: permeability, binding to penicillin-binding proteins, and stability to hydrolysis by beta-lactamases.
    Yang Y; Bhachech N; Bush K
    J Antimicrob Chemother; 1995 Jan; 35(1):75-84. PubMed ID: 7768785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo evaluation of BO-2727 against imipenem- and/or meropenem-resistant Pseudomonas aeruginosa.
    Shibata K; Adachi Y; Kato E; Nagano R; Fuse A; Hashizume T; Ohtake N; Okamoto O; Nakagawa S
    J Antibiot (Tokyo); 1997 Feb; 50(2):135-8. PubMed ID: 9099222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of carbapenem BMS-181139 against Pseudomonas aeruginosa is not dependent on porin protein D2.
    Fung-Tomc JC; Gradelski E; Kolek B; Minassian B; Pucci M; Kessler RE; Bonner DP
    Antimicrob Agents Chemother; 1995 Feb; 39(2):386-93. PubMed ID: 7726503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of LJC10,627, a new carbapenem antibiotic with high stability to dehydropeptidase I.
    Ubukata K; Hikida M; Yoshida M; Nishiki K; Furukawa Y; Tashiro K; Konno M; Mitsuhashi S
    Antimicrob Agents Chemother; 1990 Jun; 34(6):994-1000. PubMed ID: 2203313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial activity of SM-17466, a novel carbapenem antibiotic with potent activity against methicillin-resistant Staphylococcus aureus.
    Sumita Y; Nouda H; Kanazawa K; Fukasawa M
    Antimicrob Agents Chemother; 1995 Apr; 39(4):910-6. PubMed ID: 7785994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibacterial properties of meropenem towards clinical isolates, beta-lactamase producers and laboratory mutants.
    Wiedemann B; Zühlsdorf M
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():197-205. PubMed ID: 2681124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative in-vitro activity of carbapenem antibiotics against respiratory pathogens isolated between 1999 and 2000.
    Watanabe A; Tokue Y; Takahashi H; Kikuchi T; Kobayashi T; Gomi K; Fujimura S; Yasui S; Murayama Y; Nukiwa T
    J Infect Chemother; 2001 Dec; 7(4):267-71. PubMed ID: 11810597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial activity of the new carbapenem biapenem compared to imipenem, meropenem and other broad-spectrum beta-lactam drugs.
    Sader HS; Jones RN
    Eur J Clin Microbiol Infect Dis; 1993 May; 12(5):384-91. PubMed ID: 8354307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antibacterial activity of panipenem against clinical isolates in 2000 and 2001].
    Abe T; Fukuoka T; Sato Y; Ito K; Sei M
    Jpn J Antibiot; 2002 Dec; 55(6):808-26. PubMed ID: 12621735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro antibacterial activity of Sch 34343 and its stability to beta-lactamases and renal dehydropeptidase 1.
    Matsuda K; Sasaki K; Inoue K; Kondo H; Inoue M; Mitsuhashi S
    Antimicrob Agents Chemother; 1985 Nov; 28(5):684-8. PubMed ID: 3879159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.